CONTACT-01: A Randomized Phase III Trial of Atezolizumab + Cabozantinib Versus Docetaxel for Metastatic Non–Small Cell Lung Cancer After a Checkpoint Inhibitor and Chemotherapy.

Details

Language :

English

ISSN :

0732183X

Volume :

42

Issue :

20

Database :

Supplemental Index

Journal :

Journal of Clinical Oncology

Publication Type :

Academic Journal

Accession number :

178228260

Full Text :

https://doi.org/10.1200/JCO.23.02166